CPN2

CPN2 is the large regulatory subunit of carboxypeptidase N (CPN), a heterotetrameric plasma zinc metalloprotease composed of two catalytic CPN1 subunits and two CPN2 subunits, in which CPN2 protects CPN1 from proteolytic degradation in the bloodstream (PMID:14687935). Crystallographic analysis of the CPN1 catalytic domain shows that each CPN1 subunit engages the leucine-rich repeat tandem domain of its cognate CPN2 subunit through a hydrophobic surface patch at the catalytic domain–transthyretin interface, exposing the active centers and explaining how CPN2 stabilizes CPN1 within the tetramer (PMID:17157876). The assembled enzyme cleaves C-terminal arginines and lysines from complement anaphylatoxins (C3a, C5a) and kinins to modulate their activity; genetic disruption of the catalytic subunit demonstrates that intact CPN is non-redundantly required in vivo to inactivate C5a and protect against lethal anaphylactic shock, and that CPN2 alone cannot confer enzymatic activity (PMID:19414808). Independently, CPN2 suppresses NF-κB pathway activation in testicular cells, where it limits inflammatory cytokine production, preserves spermatogonial stem cell proliferation, and reduces apoptosis through a CPN2/NF-κB regulatory axis (PMID:40720213).

1. 2004 Medium

   Established the subunit architecture and enzymatic role of CPN, defining CPN2 as the large subunit that stabilizes the catalytic CPN1 subunit and placing the complex in anaphylatoxin and kinin regulation.

   Evidence Biochemical characterization and synthesis of CPN subunit composition and substrate specificity

   PMID:14687935

   Open questions at the time

   • Review synthesis rather than new primary data
   • Molecular basis of CPN2-mediated CPN1 stabilization not resolved at this stage
2. 2006 High

   Resolved the structural basis for how CPN2 stabilizes CPN1, showing the LRR tandem domain of CPN2 binds a hydrophobic patch at the CPN1 catalytic domain–transthyretin interface while leaving the active centers exposed.

   Evidence X-ray crystallography of recombinant truncated CPN1 at 2.1 Å with modeling of subunit interactions

   PMID:17157876

   Open questions at the time

   • Structure is of CPN1; CPN2 interaction is modeled rather than directly crystallized
   • Full tetramer assembly not experimentally solved
3. 2009 High

   Demonstrated that intact CPN is physiologically essential and non-redundant for C5a inactivation in vivo, and that CPN2 alone is insufficient for enzymatic function.

   Evidence Targeted CPN1 knockout mice with in vivo C5a/C3a challenge and genetic epistasis using C5aR/C3aR double knockouts plus pharmacologic rescue

   PMID:19414808

   Open questions at the time

   • Phenotype derives from CPN1 disruption, not direct CPN2 knockout
   • Does not isolate CPN2-specific functional contributions
4. 2025 Medium

   Identified a function for CPN2 beyond the CPN protease complex, placing it as a suppressor of NF-κB-mediated inflammation that protects testicular tissue and spermatogonial stem cells.

   Evidence CRISPR/Cas9 knockout rats and overexpression in a DBP-induced cryptorchidism model with Western blotting, histology, co-culture, and NF-κB activation/inhibition

   PMID:40720213

   Open questions at the time

   • Single lab and single disease model
   • Molecular mechanism linking CPN2 to NF-κB suppression unresolved
   • Relationship between this role and the CPN protease function unknown

• How CPN2 mechanistically suppresses NF-κB signaling, and whether this activity is connected to its role as the CPN protease regulatory subunit, remains unresolved.
• No direct molecular partner linking CPN2 to NF-κB identified
• No structural or biochemical model for CPN2 outside the CPN tetramer